| Basics |
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
|
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$90.66B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 0.92%
|
| Avg Daily Range (30 D): |
$0.43 | 0.96%
|
| Avg Daily Range (90 D): |
$0.47 | 1.02%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.4M |
| Avg Daily Volume (30 D): |
13.52M |
| Avg Daily Volume (90 D): |
10.9M |
| Trade Size |
| Avg Trade Size (Sh.): |
180 |
| Avg Trade Size (Sh.) (30 D): |
119 |
| Avg Trade Size (Sh.) (90 D): |
110 |
| Institutional Trades |
| Total Inst.Trades: |
125,690 |
| Avg Inst. Trade: |
$5.01M |
| Avg Inst. Trade (30 D): |
$5.91M |
| Avg Inst. Trade (90 D): |
$6.25M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
22 |
| Market Closing Trades |
| Avg Closing Trade: |
$55.73M |
| Avg Closing Trade (30 D): |
$104.83M |
| Avg Closing Trade (90 D): |
$99.03M |
| Avg Closing Volume: |
1.04M |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$2.49
|
$.64
|
$1.21
|
|
Diluted EPS
|
$2.49
|
$.64
|
$1.2
|
|
Revenue
|
$ 47.7B
|
$ 12.27B
|
$ 11.2B
|
|
Gross Profit
|
$ 33.53B
|
$ 8.9B
|
$ 8.17B
|
|
Net Income / Loss
|
$ 5.07B
|
$ 1.31B
|
$ 2.46B
|
|
Operating Income / Loss
|
$ 6.6B
|
$ 1.77B
|
$ 2.97B
|
|
Cost of Revenue
|
$ 14.17B
|
$ 3.37B
|
$ 3.03B
|
|
Net Cash Flow
|
$ 6.32B
|
$ 1.74B
|
$ 528M
|
|
PE Ratio
|
17.63
|
|
|
|
|
|
